4-氯-1.5-萘啶, 98%,4-Chloro-1,5-naphthyridine
产品编号：西域试剂-WR177645| CAS NO：7689-63-6| MDL NO：MFCD07787239| 分子式：C8H5ClN2| 分子量：164.59
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，
| 英文名称 | 4-Chloro-1,5-naphthyridine |
|---|---|
| CAS编号 | 7689-63-6 |
| 产品熔点 | 102-103ºC |
| 产品沸点 | 269.2±20.0 °C at 760 mmHg |
| 产品密度 | 1.4±0.1 g/cm3 |
| 产品闪点 | 142.5±7.4 °C |
| 精确质量 | 164.014130 |
| PSA | 25.78000 |
| LogP | 0.89 |
| 蒸气压 | 0.0±0.5 mmHg at 25°C |
| 折射率 | 1.663 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
| 海关编码 | 2933990090 |
|---|
|
~61%
7689-63-6 |
| 文献：Sieb, David; Schuhen, Katrin; Morgen, Michael; Herrmann, Heike; Wadepohl, Hubert; Lucas, Nigel T.; Baker, Robert W.; Enders, Markus Organometallics, 2012 , vol. 31, # 1 p. 356 - 364 |
|
~40%
7689-63-6 |
| 文献：Nishimura, Nobuko; Siegmund, Aaron; Liu, Longbin; Yang, Kevin; Bryan, Marian C.; Andrews, Kristin L.; Bo, Yunxin; Booker, Shon K.; Caenepeel, Sean; Freeman, Daniel; Liao, Hongyu; McCarter, John; Mullady, Erin L.; San Miguel, Tisha; Subramanian, Raju; Tamayo, Nuria; Wang, Ling; Whittington, Douglas A.; Zalameda, Leeanne; Zhang, Nancy; Hughes, Paul E.; Norman, Mark H. Journal of Medicinal Chemistry, 2011 , vol. 54, # 13 p. 4735 - 4751 |
|
~%
7689-63-6 |
| 文献：Adams et al. Journal of the American Chemical Society, 1946 , vol. 68, p. 1317 |
|
~36%
7689-63-6 |
| 文献：VIFOR (INTERNATIONAL) AG Patent: US2012/214803 A1, 2012 ; Location in patent: Page/Page column 174 ; US 20120214803 A1 |
|
~%
7689-63-6 |
| 文献：VIFOR (INTERNATIONAL) AG Patent: US2012/214803 A1, 2012 ; US 20120214803 A1 |
|
~%
7689-63-6 |
| 文献：Nishimura, Nobuko; Siegmund, Aaron; Liu, Longbin; Yang, Kevin; Bryan, Marian C.; Andrews, Kristin L.; Bo, Yunxin; Booker, Shon K.; Caenepeel, Sean; Freeman, Daniel; Liao, Hongyu; McCarter, John; Mullady, Erin L.; San Miguel, Tisha; Subramanian, Raju; Tamayo, Nuria; Wang, Ling; Whittington, Douglas A.; Zalameda, Leeanne; Zhang, Nancy; Hughes, Paul E.; Norman, Mark H. Journal of Medicinal Chemistry, 2011 , vol. 54, # 13 p. 4735 - 4751 |
|
~%
7689-63-6 |
| 文献：INFINITY PHARMACEUTICALS INC.; INTELLIKINE, LLC; CASTRO, Alfredo, C.; EVANS, Catherine, A.; JANARDANANNAIR, Somarajannair; LESCARBEAU, Andre; LIU, Tao; SNYDER, Daniel, A.; TREMBLAY, Martin, R.; REN, Pingda; LIU, Yi; LI, Liansheng; CHAN, Katrina Patent: WO2013/12915 A1, 2013 ; WO 2013/012915 A1 |
|
~%
7689-63-6 |
| 文献：INFINITY PHARMACEUTICALS INC.; INTELLIKINE, LLC; CASTRO, Alfredo, C.; EVANS, Catherine, A.; JANARDANANNAIR, Somarajannair; LESCARBEAU, Andre; LIU, Tao; SNYDER, Daniel, A.; TREMBLAY, Martin, R.; REN, Pingda; LIU, Yi; LI, Liansheng; CHAN, Katrina Patent: WO2013/12915 A1, 2013 ; WO 2013/012915 A1 |
| 上游产品 5 | |
|---|---|
| 下游产品 3 | |
![[1,5]萘啶-4-羧酸结构式](/20230522/79426-14-5.png)
浙公网安备 33010802013016号